Ingredion (INGR) CEO James Zallie awarded 28,829 RSUs vesting in 2029

Rhea-AI Filing Summary

Ingredion Inc reported that President and CEO James P. Zallie acquired 28,829 shares of common stock on a grant/award basis, valued at $117.94 per share. These are restricted stock units issued under the company’s stock incentive plan.

The RSUs may be settled only in common stock on a one-for-one basis and are scheduled to vest on February 25, 2029. They vest on a pro-rata basis if employment ends due to death, disability, or retirement, and in the case of retirement on or after February 25, 2027, they continue vesting under the original schedule.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Zallie James P.

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,829	$117.94	$3.40M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 61,839.579 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zallie James P.

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		28,829(1)	A	$117.94	61,839.579	D
Common Stock								73,530	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on February 25, 2029. In the event of termination of employment due to (a) death (b) disability or (c) retirement (as defined in the grant agreement), the RSUs will vest on a pro-rata basis. Notwithstanding the foregoing, in the event of Retirement on or after February 25, 2027, the RSUs shall continue to vest in accordance with the vesting schedule.

	Michael N. Levy, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ingredion (INGR) CEO James P. Zallie report in this Form 4?

James P. Zallie reported an acquisition of 28,829 shares of Ingredion common stock through a grant of restricted stock units. The award was priced at $117.94 per share and was issued under the Ingredion Incorporated Stock Incentive Plan.

Are the 28,829 units in the Ingredion (INGR) Form 4 an open-market stock purchase?

No, the 28,829 units are a grant of restricted stock units, not an open-market stock purchase. They were awarded under Ingredion’s stock incentive plan and may be settled only in common shares on a one-for-one basis at vesting.

When do the restricted stock units granted to the Ingredion (INGR) CEO vest?

The restricted stock units granted to the CEO are scheduled to vest on February 25, 2029. This is the standard vesting date, subject to earlier pro-rata vesting in cases of death, disability, or qualifying retirement under the grant agreement.

How are the Ingredion (INGR) CEO’s RSUs affected by death, disability, or retirement?

If the CEO’s employment ends due to death, disability, or retirement, the restricted stock units vest on a pro-rata basis. For retirement on or after February 25, 2027, the RSUs continue to follow the original vesting schedule through the 2029 vesting date.

What is the settlement method for the Ingredion (INGR) CEO’s restricted stock units?

The restricted stock units can be settled only in Ingredion common stock at a one-to-one ratio. Each RSU converts into one share of common stock upon vesting under the terms of the Ingredion Incorporated Stock Incentive Plan and the applicable grant agreement.